| Authors: |
Peláez R; Department of Oncology, Center for Applied Medical Research CIMA, Pamplona, Spain.; Biomarkers and Molecular Signaling Group, Neurodegenerative Diseases Area, Center for Biomedical Research of La Rioja, CIBIR, Logroño, Spain., Morales X; Department of Oncology, Center for Applied Medical Research CIMA, Pamplona, Spain.; Laboratory of Preclinical Models and Analytical Tools, Division of Solid Tumors and Biomarkers, Center for Applied Medical Research and CIBERONC, Pamplona, Navarra, Spain., Salvo E; Department of Oncology, Center for Applied Medical Research CIMA, Pamplona, Spain., Garasa S; Department of Oncology, Center for Applied Medical Research CIMA, Pamplona, Spain.; Department of Immunology and Immunotherapy, CIMA, Pamplona, Navarra, Spain., Ortiz de Solórzano C; Laboratory of Preclinical Models and Analytical Tools, Division of Solid Tumors and Biomarkers, Center for Applied Medical Research and CIBERONC, Pamplona, Navarra, Spain., Martínez A; Oncology Area, Center for Biomedical Research of La Rioja, CIBIR, Logroño, Spain., Larrayoz IM; Biomarkers and Molecular Signaling Group, Neurodegenerative Diseases Area, Center for Biomedical Research of La Rioja, CIBIR, Logroño, Spain., Rouzaut A; Department of Oncology, Center for Applied Medical Research CIMA, Pamplona, Spain.; Department of Immunology and Immunotherapy, CIMA, Pamplona, Navarra, Spain.; Department of Biochemistry and Genetics, University of Navarra, Pamplona, Spain. |
